What is the Projected CAGR value of the North America Viral Vector And Plasmid Dna Manufacturing Market ?
North America Viral Vector And Plasmid Dna Manufacturing Market is expected to grow at a CAGR of 2.8% during the forecast period 2023-2030.
Who are the key players in the North America Viral Vector And Plasmid Dna Manufacturing Market ?
Major players are Lonza, Merck, Oxford BioMedica, CGT Catapult, Cobra Biologics, UniQure, Sanofi, FUJIFILM Diosynth Biotechnologies, Cobra Biologics, Thermo Fisher Scientific, Inc. and Spark Therapeutics.